BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 14738146)

  • 1. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia.
    Casas S; Nagy B; Elonen E; Aventín A; Larramendy ML; Sierra J; Ruutu T; Knuutila S
    Leuk Lymphoma; 2003 Nov; 44(11):1935-41. PubMed ID: 14738146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overexpression of translocation-associated fusion genes of FGFRI, MYC, NPMI, and DEK, but absence of the translocations in acute myeloid leukemia. A microarray analysis.
    Larramendy ML; Niini T; Elonen E; Nagy B; Ollila J; Vihinen M; Knuutila S
    Haematologica; 2002 Jun; 87(6):569-77. PubMed ID: 12031912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transformation of human CD34+ hematopoietic progenitor cells with DEK-NUP214 induces AML in an immunocompromised mouse model.
    Qin H; Malek S; Cowell JK; Ren M
    Oncogene; 2016 Oct; 35(43):5686-5691. PubMed ID: 27065320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The chromosome translocation t(7;11)(p15;p15) in acute myeloid leukemia results in fusion of the NUP98 gene with a HOXA cluster gene, HOXA13, but not HOXA9.
    Taketani T; Taki T; Ono R; Kobayashi Y; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2002 Aug; 34(4):437-43. PubMed ID: 12112533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
    Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling of acute myeloid leukemia with translocation t(8;16)(p11;p13) and MYST3-CREBBP rearrangement reveals a distinctive signature with a specific pattern of HOX gene expression.
    Camós M; Esteve J; Jares P; Colomer D; Rozman M; Villamor N; Costa D; Carrió A; Nomdedéu J; Montserrat E; Campo E
    Cancer Res; 2006 Jul; 66(14):6947-54. PubMed ID: 16849538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEK oncogene expression during normal hematopoiesis and in Acute Myeloid Leukemia (AML).
    Logan GE; Mor-Vaknin N; Braunschweig T; Jost E; Schmidt PV; Markovitz DM; Mills KI; Kappes F; Percy MJ
    Blood Cells Mol Dis; 2015 Jan; 54(1):123-31. PubMed ID: 25128083
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUP98-HOXA9 bearing therapy-related myeloid neoplasm involves myeloid-committed cell and induces HOXA5, EVI1, FLT3, and MEIS1 expression.
    Burillo-Sanz S; Morales-Camacho RM; Caballero-Velázquez T; Vargas MT; García-Lozano JR; Falantes JF; Prats-Martín C; Bernal R; Pérez-Simón JA
    Int J Lab Hematol; 2016 Feb; 38(1):64-71. PubMed ID: 26418229
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical and biological characteristics in childhood acute myeloid leukemia with 8;21 translocation].
    He J; Xue Y; He H; Li J; Song X; Huang Y; He Y; Zhang X; Chai Y; Zhu L
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):512-4. PubMed ID: 15476184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of t(8;21) acute myeloid leukemia (AML) with additional chromosomal abnormality: concomitant trisomy 4 may constitute a distinctive subtype of t(8;21) AML.
    Nishii K; Usui E; Katayama N; Lorenzo F; Nakase K; Kobayashi T; Miwa H; Mizutani M; Tanaka I; Nasu K; Dohy H; Kyo T; Taniwaki M; Ueda T; Kita K; Shiku H
    Leukemia; 2003 Apr; 17(4):731-7. PubMed ID: 12682630
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical and laboratory study of a complex translocation t (6; 21; 8) (p22; q22; q22) in two patients with acute myeloid leukemia].
    Gong JY; Liu XP; Li CW; Zhao XC; Dai Y; Qin S; Xiao JG; Huang Q; Xu FY; Wang F; Cui W; Liu SH; Wang JX
    Zhonghua Xue Ye Xue Za Zhi; 2006 May; 27(5):314-7. PubMed ID: 16875580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A complex karyotype masked a cryptic variant t(8;21)(q22;q22) in a child with acute myeloid leukemia.
    De Figueiredo AF; Liehr T; Bhatt S; Binato R; De Souza MT; De Matos RR; Salles Tde J; Jordy FC; Ribeiro RC; Abdelhay E; Silva ML
    Leuk Lymphoma; 2011 Aug; 52(8):1593-6. PubMed ID: 21657952
    [No Abstract]   [Full Text] [Related]  

  • 13. Orbital tumor in acute myeloid leukemia associated with karyotype 46,XX,t(8;21)(q22;q22): a case report.
    Tanigawa M; Tsuda Y; Amemiya T; Yamada K; Nakayama M; Tsuji Y
    Ophthalmologica; 1998; 212(3):202-5. PubMed ID: 9562099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequent co-expression of the HOXA9 and MEIS1 homeobox genes in human myeloid leukemias.
    Lawrence HJ; Rozenfeld S; Cruz C; Matsukuma K; Kwong A; Kömüves L; Buchberg AM; Largman C
    Leukemia; 1999 Dec; 13(12):1993-9. PubMed ID: 10602420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. t(3;21)(q26;q22) in myeloid leukemia: an aggressive syndrome of blast transformation associated with hydroxyurea or antimetabolite therapy.
    Yin CC; Cortes J; Barkoh B; Hayes K; Kantarjian H; Jones D
    Cancer; 2006 Apr; 106(8):1730-8. PubMed ID: 16532439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. t(6;9)(p22;q34)/DEK-NUP214-rearranged pediatric myeloid leukemia: an international study of 62 patients.
    Sandahl JD; Coenen EA; Forestier E; Harbott J; Johansson B; Kerndrup G; Adachi S; Auvrignon A; Beverloo HB; Cayuela JM; Chilton L; Fornerod M; de Haas V; Harrison CJ; Inaba H; Kaspers GJ; Liang DC; Locatelli F; Masetti R; Perot C; Raimondi SC; Reinhardt K; Tomizawa D; von Neuhoff N; Zecca M; Zwaan CM; van den Heuvel-Eibrink MM; Hasle H
    Haematologica; 2014 May; 99(5):865-72. PubMed ID: 24441146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nup98-HoxA9 immortalizes myeloid progenitors, enforces expression of Hoxa9, Hoxa7 and Meis1, and alters cytokine-specific responses in a manner similar to that induced by retroviral co-expression of Hoxa9 and Meis1.
    Calvo KR; Sykes DB; Pasillas MP; Kamps MP
    Oncogene; 2002 Jun; 21(27):4247-56. PubMed ID: 12082612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BP1, a new homeobox gene, is frequently expressed in acute leukemias.
    Haga SB; Fu S; Karp JE; Ross DD; Williams DM; Hankins WD; Behm F; Ruscetti FW; Chang M; Smith BD; Becton D; Raimondi SC; Berg PE
    Leukemia; 2000 Nov; 14(11):1867-75. PubMed ID: 11069021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.